Global Colistin Sulfate Market Growth 2023-2029

Global Colistin Sulfate Market Growth 2023-2029

Colistin, also known as polymyxin E, is an antibiotic produced by certain strains of the bacteria Paenibacillus polymyxa. Colistin is a mixture of the cyclic polypeptides colistin A and B and belongs to the class of polypeptide antibiotics known as polymyxins. Colistin is effective against most Gram-negative bacilli.

LPI (LP Information)' newest research report, the “Colistin Sulfate Industry Forecast” looks at past sales and reviews total world Colistin Sulfate sales in 2022, providing a comprehensive analysis by region and market sector of projected Colistin Sulfate sales for 2023 through 2029. With Colistin Sulfate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Colistin Sulfate industry.

This Insight Report provides a comprehensive analysis of the global Colistin Sulfate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Colistin Sulfate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Colistin Sulfate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Colistin Sulfate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Colistin Sulfate.

The global Colistin Sulfate market size is projected to grow from US$ 57 million in 2022 to US$ 71 million in 2029; it is expected to grow at a CAGR of 71 from 2023 to 2029.

Global Colistin Sulphate key players include Shengxue Dacheng , Apeloa, LKPC, Xellia, Shenghua Biok, etc. Global top five manufacturers hold a share about 55%.

China is the largest market, with a share over 75%, followed by Japan and Europe, both have a share over 10 percent.

In terms of product, Colistin Sulphate API is the largest segment, with a share over 90%. And in terms of application, the largest application is Chicken Colistin Sulphate, followed by Pig Colistin Sulphate.

This report presents a comprehensive overview, market shares, and growth opportunities of Colistin Sulfate market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Min Purity Less Than 95%
Min Purity More Than 95%

Segmentation by application
Research
Medical
Veterinary

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Xellia Pharmaceuticals
Tecoland
Clearsynth
JSN Chemicals
SNA Health Care
HBCChem
U.K. Vet Chem
Meiji
Fengchen Group
Fujian Lifecome Biochemistry
Sinopharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Colistin Sulfate market?

What factors are driving Colistin Sulfate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Colistin Sulfate market opportunities vary by end market size?

How does Colistin Sulfate break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.